Clinical course of solitary extramedullary plasmacytoma

Robert H. Liebross, Chul S Ha, James D. Cox, Donna Weber, Kay Delasalle, Raymond Alexanian

Research output: Contribution to journalArticle

184 Citations (Scopus)

Abstract

Background and purpose: Solitary extramedullary plasmacytoma (EMP) represents a rare category of malignant disease on which there are limited data in regard to diagnosis, staging and natural history. This study attempted to clarify the clinical course of solitary extramedullary plasmacytoma after radiation or surgical therapy given with curative intent. Materials and methods: The diagnosis was based on a mass of clonal plasma cells separate from bone or bone marrow without evidence of occult disease elsewhere. Between 1963 and 1996, 22 previously untreated patients with an EMP were diagnosed. Disease presented in the head or neck in 86%, usually in the nasal cavity (NC) or maxillary sinus (MS), and in these areas local bone destruction was found in 10 of 11 patients. Among all patients, serum myeloma protein was present in three patients (14%) and Bence Jones protein alone was found in two patients (9%). Radiation therapy was the sole treatment for 18 of 22 patients, and the median radiotherapy dose was 50 Gy (range, 40-60 Gy); five of seven patients with an EMP of oral cavity (OC), oropharynx (OP), nasopharynx (NP), parotid or larynx also received elective neck irradiation. Two patients underwent surgery plus postoperative irradiation of a plasmacytoma of the sigmoid colon or pleura, and two patients had resection alone of a plasmacytoma of the colon or cervical lymph node. Results: Local control was achieved in 21 of 22 patients (95%), and disease never recurred in regional nodes. Disappearance of myeloma protein occurred in three of five patients with an evaluable abnormality. Multiple myeloma developed in seven patients (32%), all within 5 years. The 5-year rate of freedom from progression to multiple myeloma was 56% and the median survival was 9.5 years. Conclusion: Radiation therapy achieved excellent locoregional control of EMP with an approximate cure fraction of 50%.

Original languageEnglish (US)
Pages (from-to)245-249
Number of pages5
JournalRadiotherapy and Oncology
Volume52
Issue number3
DOIs
StatePublished - Sep 1 1999
Externally publishedYes

Fingerprint

Plasmacytoma
Myeloma Proteins
Radiotherapy
Multiple Myeloma
Neck
Bence Jones Protein
Bone and Bones
Oropharynx
Nasopharynx
Pleura
Maxillary Sinus
Paranasal Sinuses
Nasal Cavity
Sigmoid Colon
Larynx
Plasma Cells
Natural History
Mouth
Blood Proteins
Colon

Keywords

  • Extramedullary
  • Myeloma
  • Plasmacytoma
  • Radiation therapy

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Urology

Cite this

Liebross, R. H., Ha, C. S., Cox, J. D., Weber, D., Delasalle, K., & Alexanian, R. (1999). Clinical course of solitary extramedullary plasmacytoma. Radiotherapy and Oncology, 52(3), 245-249. https://doi.org/10.1016/S0167-8140(99)00114-0

Clinical course of solitary extramedullary plasmacytoma. / Liebross, Robert H.; Ha, Chul S; Cox, James D.; Weber, Donna; Delasalle, Kay; Alexanian, Raymond.

In: Radiotherapy and Oncology, Vol. 52, No. 3, 01.09.1999, p. 245-249.

Research output: Contribution to journalArticle

Liebross, RH, Ha, CS, Cox, JD, Weber, D, Delasalle, K & Alexanian, R 1999, 'Clinical course of solitary extramedullary plasmacytoma', Radiotherapy and Oncology, vol. 52, no. 3, pp. 245-249. https://doi.org/10.1016/S0167-8140(99)00114-0
Liebross, Robert H. ; Ha, Chul S ; Cox, James D. ; Weber, Donna ; Delasalle, Kay ; Alexanian, Raymond. / Clinical course of solitary extramedullary plasmacytoma. In: Radiotherapy and Oncology. 1999 ; Vol. 52, No. 3. pp. 245-249.
@article{b6ccb3e7f0fc4ec79b433050e78cc861,
title = "Clinical course of solitary extramedullary plasmacytoma",
abstract = "Background and purpose: Solitary extramedullary plasmacytoma (EMP) represents a rare category of malignant disease on which there are limited data in regard to diagnosis, staging and natural history. This study attempted to clarify the clinical course of solitary extramedullary plasmacytoma after radiation or surgical therapy given with curative intent. Materials and methods: The diagnosis was based on a mass of clonal plasma cells separate from bone or bone marrow without evidence of occult disease elsewhere. Between 1963 and 1996, 22 previously untreated patients with an EMP were diagnosed. Disease presented in the head or neck in 86{\%}, usually in the nasal cavity (NC) or maxillary sinus (MS), and in these areas local bone destruction was found in 10 of 11 patients. Among all patients, serum myeloma protein was present in three patients (14{\%}) and Bence Jones protein alone was found in two patients (9{\%}). Radiation therapy was the sole treatment for 18 of 22 patients, and the median radiotherapy dose was 50 Gy (range, 40-60 Gy); five of seven patients with an EMP of oral cavity (OC), oropharynx (OP), nasopharynx (NP), parotid or larynx also received elective neck irradiation. Two patients underwent surgery plus postoperative irradiation of a plasmacytoma of the sigmoid colon or pleura, and two patients had resection alone of a plasmacytoma of the colon or cervical lymph node. Results: Local control was achieved in 21 of 22 patients (95{\%}), and disease never recurred in regional nodes. Disappearance of myeloma protein occurred in three of five patients with an evaluable abnormality. Multiple myeloma developed in seven patients (32{\%}), all within 5 years. The 5-year rate of freedom from progression to multiple myeloma was 56{\%} and the median survival was 9.5 years. Conclusion: Radiation therapy achieved excellent locoregional control of EMP with an approximate cure fraction of 50{\%}.",
keywords = "Extramedullary, Myeloma, Plasmacytoma, Radiation therapy",
author = "Liebross, {Robert H.} and Ha, {Chul S} and Cox, {James D.} and Donna Weber and Kay Delasalle and Raymond Alexanian",
year = "1999",
month = "9",
day = "1",
doi = "10.1016/S0167-8140(99)00114-0",
language = "English (US)",
volume = "52",
pages = "245--249",
journal = "Radiotherapy and Oncology",
issn = "0167-8140",
publisher = "Elsevier Ireland Ltd",
number = "3",

}

TY - JOUR

T1 - Clinical course of solitary extramedullary plasmacytoma

AU - Liebross, Robert H.

AU - Ha, Chul S

AU - Cox, James D.

AU - Weber, Donna

AU - Delasalle, Kay

AU - Alexanian, Raymond

PY - 1999/9/1

Y1 - 1999/9/1

N2 - Background and purpose: Solitary extramedullary plasmacytoma (EMP) represents a rare category of malignant disease on which there are limited data in regard to diagnosis, staging and natural history. This study attempted to clarify the clinical course of solitary extramedullary plasmacytoma after radiation or surgical therapy given with curative intent. Materials and methods: The diagnosis was based on a mass of clonal plasma cells separate from bone or bone marrow without evidence of occult disease elsewhere. Between 1963 and 1996, 22 previously untreated patients with an EMP were diagnosed. Disease presented in the head or neck in 86%, usually in the nasal cavity (NC) or maxillary sinus (MS), and in these areas local bone destruction was found in 10 of 11 patients. Among all patients, serum myeloma protein was present in three patients (14%) and Bence Jones protein alone was found in two patients (9%). Radiation therapy was the sole treatment for 18 of 22 patients, and the median radiotherapy dose was 50 Gy (range, 40-60 Gy); five of seven patients with an EMP of oral cavity (OC), oropharynx (OP), nasopharynx (NP), parotid or larynx also received elective neck irradiation. Two patients underwent surgery plus postoperative irradiation of a plasmacytoma of the sigmoid colon or pleura, and two patients had resection alone of a plasmacytoma of the colon or cervical lymph node. Results: Local control was achieved in 21 of 22 patients (95%), and disease never recurred in regional nodes. Disappearance of myeloma protein occurred in three of five patients with an evaluable abnormality. Multiple myeloma developed in seven patients (32%), all within 5 years. The 5-year rate of freedom from progression to multiple myeloma was 56% and the median survival was 9.5 years. Conclusion: Radiation therapy achieved excellent locoregional control of EMP with an approximate cure fraction of 50%.

AB - Background and purpose: Solitary extramedullary plasmacytoma (EMP) represents a rare category of malignant disease on which there are limited data in regard to diagnosis, staging and natural history. This study attempted to clarify the clinical course of solitary extramedullary plasmacytoma after radiation or surgical therapy given with curative intent. Materials and methods: The diagnosis was based on a mass of clonal plasma cells separate from bone or bone marrow without evidence of occult disease elsewhere. Between 1963 and 1996, 22 previously untreated patients with an EMP were diagnosed. Disease presented in the head or neck in 86%, usually in the nasal cavity (NC) or maxillary sinus (MS), and in these areas local bone destruction was found in 10 of 11 patients. Among all patients, serum myeloma protein was present in three patients (14%) and Bence Jones protein alone was found in two patients (9%). Radiation therapy was the sole treatment for 18 of 22 patients, and the median radiotherapy dose was 50 Gy (range, 40-60 Gy); five of seven patients with an EMP of oral cavity (OC), oropharynx (OP), nasopharynx (NP), parotid or larynx also received elective neck irradiation. Two patients underwent surgery plus postoperative irradiation of a plasmacytoma of the sigmoid colon or pleura, and two patients had resection alone of a plasmacytoma of the colon or cervical lymph node. Results: Local control was achieved in 21 of 22 patients (95%), and disease never recurred in regional nodes. Disappearance of myeloma protein occurred in three of five patients with an evaluable abnormality. Multiple myeloma developed in seven patients (32%), all within 5 years. The 5-year rate of freedom from progression to multiple myeloma was 56% and the median survival was 9.5 years. Conclusion: Radiation therapy achieved excellent locoregional control of EMP with an approximate cure fraction of 50%.

KW - Extramedullary

KW - Myeloma

KW - Plasmacytoma

KW - Radiation therapy

UR - http://www.scopus.com/inward/record.url?scp=0032829468&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032829468&partnerID=8YFLogxK

U2 - 10.1016/S0167-8140(99)00114-0

DO - 10.1016/S0167-8140(99)00114-0

M3 - Article

C2 - 10580871

AN - SCOPUS:0032829468

VL - 52

SP - 245

EP - 249

JO - Radiotherapy and Oncology

JF - Radiotherapy and Oncology

SN - 0167-8140

IS - 3

ER -